HERE'S A FEW OF OUR 6000+ Facebook & MySpace FRIENDS
Timothy L. Vollmer M.D. Department of Neurology
University of Colorado Health Sciences Center
Co-Director of the RMMSC at Anschutz Medical Center
and
Medical Director-Rocky Mountain MS Center
"MS Can Not
Rob You of Joy"
"I'm an M.D....my Mom has MS and we have a message for everyone."
- Jennifer Hartmark-Hill MD
Beverly Dean
"I've had MS for 2 years...this is the most important advice you'll ever hear."
"This is how I give myself a painless injection."
Heather Johnson
"A helpful tip for newly diagnosed MS patients."
"Important advice on choosing MS medication "
Joyce Moore
Thursday
FANTASTIC COPAXONE NEWS FOR MSers!!!
FANTASTIC COPAXONE NEWS FOR MSers!!! Higher Dose of Copaxone with fewer injections a week!
This is professor and chair of neurology at the Wayne State University School of Medicine. Credit: Wayne State University Global research overseen by and conducted at the Wayne State University School of Medicine will immediately change the treatment regimen of millions of multiple sclerosispatients around the world. The U.S. Food and Drug Administration Tuesday approved a new drug application that calls for the injection of Copaxone at a higher dose, but fewer times per week for patientswith relapsing forms of multiple sclerosis. "The availability of three-times-a-week Copaxone 40 mg/mL is a significant advancement for patients as they now have the option of effective and safe treatment with the drug, while reducing the number of injections by 60 percent," said Omar Khan, M.D., professor and chair of neurology at the Wayne State University School of Medicine. "Patients in the United States can now benefit from an improved dosing regimen without compromising the known benefits of Copaxone." The study was published in the Annals of Neurology, a leading clinical neuroscience journal and the official publication of the American Neurological Association.